Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06708715

Stress Reduction After Use of a Haptic Vibrotactile Trigger Technology Patch: Analysis and Assessment

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
SuperPatch Limited LLC · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research study is to collect subject perceptions or feelings about their treatment. Participation includes a survey from individuals who are receiving a stress or anxiety-relieving topical patch \[Super Patch PEACE Patch with Haptic Vibrotactile Trigger Technology (VTT)\] and assigned to a Treatment Group or given a Sham patch, assigned to the Control Group, to address symptoms or stress and anxiety symptoms using validated scales \[for example, The Perceived Stress Scale (PSS) or Medical Outcomes Study Short Form-20 (SF-20)\].

Detailed description

This minimal risk observational study, will evaluate an over the counter (OTC) non-invasive, non- pharmacological patch (Super Patch PEACE Patch; The Super Patch Company Ltd LLC., SRYSTY Holding Co., Toronto, Canada) that is embedded with a proprietary sensory pattern and incorporates haptic vibrotactile trigger technology (VTT) and designed to trigger neural pathways and circuits associated with stress, anxiety, and other cortical networks, with other study participants who receive an 'inactive' (Sham) patch without the embedded VTT technology. The sensory patterns within the active patches are in close symmetry between known EEG patterns and their role in modulating EEG and neuronal circuits within higher brain centers.

Conditions

Interventions

TypeNameDescription
DEVICEPEACE PatchA topical patch that incorporates a sensory pattern of vibrotactile haptic technology.
DEVICETopical Sham PatchSham Patch that does not include vibrotactile haptic technology

Timeline

Start date
2023-05-05
Primary completion
2026-05-01
Completion
2026-05-01
First posted
2024-11-27
Last updated
2025-12-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06708715. Inclusion in this directory is not an endorsement.